These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 2860135

  • 21. Alprazolam (Xanax, the Upjohn Company).
    Evans RL.
    Drug Intell Clin Pharm; 1981 Sep; 15(9):633-8. PubMed ID: 6115742
    [Abstract] [Full Text] [Related]

  • 22. [Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
    Pöldinger W.
    Schweiz Rundsch Med Prax; 1985 Oct 29; 74(44):1199-203. PubMed ID: 2867592
    [No Abstract] [Full Text] [Related]

  • 23. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP, Meredith CH, Frost NR, Chammas S, Hendrickson G.
    Acta Psychiatr Scand; 1983 Oct 29; 68(4):223-33. PubMed ID: 6138925
    [Abstract] [Full Text] [Related]

  • 24. Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
    Draper RJ, Daly I.
    Ir Med J; 1983 Nov 29; 76(11):453-6. PubMed ID: 6139353
    [No Abstract] [Full Text] [Related]

  • 25. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
    Ansseau M, Ansoms C, Beckers G, Bogaerts M, Botte L, De Buck R, Diricq S, Dumortier A, Jansegers E, Owieczka J.
    J Affect Disord; 1984 Dec 29; 7(3-4):287-96. PubMed ID: 6151958
    [Abstract] [Full Text] [Related]

  • 26. Emergence of hostility during alprazolam treatment.
    Rosenbaum JF, Woods SW, Groves JE, Klerman GL.
    Am J Psychiatry; 1984 Jun 29; 141(6):792-3. PubMed ID: 6145358
    [Abstract] [Full Text] [Related]

  • 27. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E.
    J Clin Psychiatry; 2002 Jun 29; 63 Suppl 14():27-33. PubMed ID: 12562116
    [Abstract] [Full Text] [Related]

  • 28. Recent advances in anxiolytic therapy.
    Rickels K.
    J Clin Psychiatry; 1981 Nov 29; 42(11 Pt 2):40-4. PubMed ID: 6120938
    [No Abstract] [Full Text] [Related]

  • 29. Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect.
    Srisurapanont M, Boonyanaruthee V.
    J Med Assoc Thai; 1997 Mar 29; 80(3):183-8. PubMed ID: 9175386
    [Abstract] [Full Text] [Related]

  • 30. Alprazolam in older depressed inpatients.
    Pitts WM, Fann WE, Sajadi C, Snyder S.
    J Clin Psychiatry; 1983 Jun 29; 44(6):213-5. PubMed ID: 6133850
    [Abstract] [Full Text] [Related]

  • 31. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW, Jue SG, Brogden RN.
    Drugs; 1984 Feb 29; 27(2):132-47. PubMed ID: 6141930
    [Abstract] [Full Text] [Related]

  • 32. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K, Csanalosi I, Greisman P, Cohen D, Werblowsky J, Ross HA, Harris H.
    Am J Psychiatry; 1983 Jan 29; 140(1):82-5. PubMed ID: 6128927
    [Abstract] [Full Text] [Related]

  • 33. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB, Ballenger JC, Rickels K.
    J Clin Psychiatry; 1997 Jan 29; 58 Suppl 11():11-8. PubMed ID: 9363043
    [Abstract] [Full Text] [Related]

  • 34. Refractory migraine headache controlled with alprazolam: case report.
    Othmer SC, Othmer E, Varanka TM, Strong DM.
    J Clin Psychiatry; 1985 Nov 29; 46(11):494-5. PubMed ID: 3902808
    [Abstract] [Full Text] [Related]

  • 35. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
    Greiss KC, Fogari R.
    J Clin Pharmacol; 1980 Nov 29; 20(11):693-9. PubMed ID: 6112245
    [Abstract] [Full Text] [Related]

  • 36. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G, Annable L, Fontaine R, Solyom L.
    Psychopharmacology (Berl); 1982 Nov 29; 77(3):229-33. PubMed ID: 6126907
    [Abstract] [Full Text] [Related]

  • 37. Recognition of depressive syndromes, tricyclics, and the second generation antidepressants.
    Tollefson G, Tuason VB.
    Minn Med; 1984 Jun 29; 67(6):345-50. PubMed ID: 6147748
    [No Abstract] [Full Text] [Related]

  • 38. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
    Cohn JB, Wilcox CS.
    Pharmacotherapy; 1984 Jun 29; 4(2):93-8. PubMed ID: 6144090
    [Abstract] [Full Text] [Related]

  • 39. [The influence of alprazolam on the symptoms of anxiety and depression].
    Małyszczak K, Kiejna A.
    Psychiatr Pol; 1997 Jun 29; 31(6):745-52. PubMed ID: 9515306
    [Abstract] [Full Text] [Related]

  • 40. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE, Papadopoulos A, Seddon K, Nutt DJ.
    J Psychopharmacol; 2009 Mar 29; 23(2):117-22. PubMed ID: 18562427
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.